Chemistry:APINAC

From HandWiki

APINAC (AKB-57, N-(1-adamantyl)-1-pentylindazole-3-carboxylate) is a drug that acts as an agonist for the cannabinoid receptors.[1] It was detected in Slovenia in 2016[2] and is on the UNODC list of synthetic cannabinoids.[3]

Legality

APINAC is covered by the UK blanket ban on synthetic cannabinoids.

Detection

APINAC can be bought by labs as a reference standard.[4] APINAC metabolizes to N-pentylindazole-3-carboxylic acid, hydroxylated N-pentylindrazole-3-carboxylic acid, and 1-adamantanol in rats.[1]

See also

References

  1. ↑ 1.0 1.1 "In vivo metabolism of the new synthetic cannabinoid APINAC in rats by GC–MS and LC–QTOF-MS". Forensic Toxicology 35 (2): 359–368. 2017-07-01. doi:10.1007/s11419-017-0364-y. ISSN 1860-8973. 
  2. ↑ "Analytical Report, AKB-57 (C23H30N2O2)". Slovenian National Forensic Laboratory (NFL). 2016-02-04. https://www.policija.si/apps/nfl_response_web/0_Analytical_Reports_final/AKB-57-ID-1521-16_report_final.pdf. "adamantan-1-yl 1-pentyl-1H-indazole-3-carboxylate; KCCVWUAAHDXNNQ-UHFFFAOYSA-N" 
  3. ↑ "Substance Details AKB-57". https://www.unodc.org/LSS/Substance/Details/e55768bf-de56-4c61-9d14-3f7bdc73f6d9. 
  4. ↑ "Apinac (CAS 2219331-93-6)". https://www.caymanchem.com/product/43999/apinac.